USA Polyamide prices stayed in higher range in early February window, with prices rising 3.41% during the last week of January. Early January trading was largely range-bound as buyers maintained routine procurement and operating rates stayed normal; by mid-January the market remained calm with minimal movement. Late-month dynamics changed materially when caprolactam cost inflation and upstream vendor actions prompted stronger seller offers, stimulating renewed buying interest and lifting spot sentiment across the Polyamide 6 DEL US Gulf complex.
Demand patterns were mixed through January. Industrial buyers and procurement teams kept activity steady in the early month, supporting a baseline for transactions, while broader market participants exhibited muted engagement through mid-January. In contrast, buyer interest picked up in the late month as procurement groups positioned ahead of upstream adjustments, helping to support the Polyamide 6 bid tone. Some other PA grades diverged: Polyamide 4,6 in the Los Angeles CFR market eased through mid-month, extending a short-term negative trend, illustrating that demand pressure was grade- and region-specific rather than uniform across the board.
On the supply side, BASF implemented price hikes for caprolactam and for Polyamide polymers in North America, effective immediately or as contracts allow, tightening the available cost margin for converters and prompting suppliers to firm Polyamide offers. Logistics and inventory dynamics remained broadly steady through mid-month, providing limited offset to the cost-push; there were no material plant outage reports in the data to suggest production shortages beyond margin-driven supply tightening.
Weekly pricing action underscored the shift: after several weeks of range-bound and sideways trading through early and mid-January, spot Polyamide 6 DEL US Gulf jumped in the late-January, delivering the 3.41% week-on-week increase noted above, per weekly assessment data. That move stands out as significant relative to the prior calm period and was linked in market discussions to BASF鈥檚 caprolactam-driven cost inflation and Polyamide pricing steps. Smaller grades and regions continued to show mixed behavior, but the dominant narrative for PA6 in the Gulf was a clear upward re-pricing during the late-month swing.
Looking ahead, the immediate outlook for Polyamide 6 will hinge on feedstock trajectories and whether upstream producers sustain or widen their pricing actions. If caprolactam costs remain elevated and vendors continue to press contract-level increases, further upward pressure on Polyamide 6 spot offers is likely; conversely, stable feedstock and normal procurement activity could rein in gains and allow some grades to revert to range-bound trading.
Leave a Comment
Comments (0)